article

1. An educational module to improve knowledge of delirium screening in the Emergency Department..  The American journal of emergency medicine.  311-312. 2021
2. Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients..  Gynecologic oncology.  160:477-484. 2020
3. Breast cancer endocrine therapy adherence in health professional shortage areas: Unique effects on patients with mental illness..  Journal of psychosomatic research.  -. 2020
4. Developing a Standardized and Reusable Method to Link Distributed Health Plan Databases to the National Death Index: Methods Development Study Protocol..  JMIR research protocols.  9:-. 2020
5. Exploration of PCORnet Data Resources for Assessing Use of Molecular-Guided Cancer Treatment..  JCO clinical cancer informatics.  724-735. 2020
6. Increased opioid use following rotator cuff repair associated with prior opioid use and surgeon prescription patterns..  Journal of shoulder and elbow surgery.  29:S115-S125. 2020
7. Risk Factors and Survival Analysis of Spinal Cord Stimulator Explantation..  Neuromodulation : journal of the International Neuromodulation Society.  24:61-67. 2020
8. Association of Mood and Anxiety Disorders and Opioid Prescription Patterns Among Postpartum Women..  The American journal on addictions.  29:463-470. 2020
9. Impact of Rurality on Stage IV Ovarian Cancer at Diagnosis: A Midwest Cancer Registry Cohort Study..  The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.  36:468-475. 2020
10. Staphylococcus aureus.  Open forum infectious diseases.  6:-. 2019
11. Evaluation of emergency department derived delirium prediction models using a hospital-wide cohort..  Journal of psychosomatic research.  -. 2019
12. Predictors of Reduced Opioid Use With Spinal Cord Stimulation in Patients With Chronic Opioid Use..  Neuromodulation : journal of the International Neuromodulation Society.  23:126-132. 2019
13. Recognition, prevention, and treatment of delirium in emergency department: An evidence-based narrative review..  The American journal of emergency medicine.  38:349-357. 2019
14. Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence..  Clinical breast cancer.  20:e261-e280. 2019
15. Temporal trends and factors associated with increased mortality among atrial fibrillation weekend hospitalizations: an insight from National Inpatient Sample 2005-2014..  BMC research notes.  12:-. 2019
16. An Exploratory Analysis of Real-World End Points for Assessing Outcomes Among Immunotherapy-Treated Patients With Advanced Non-Small-Cell Lung Cancer..  JCO clinical cancer informatics.  1-15. 2019
17. Anticholinergic burden and risk of cognitive impairment in elderly nursing home residents with depression..  Research in social & administrative pharmacy : RSAP.  16:329-335. 2019
18. Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users..  Pharmaceutical medicine.  33:29-43. 2019
19. Impact of Iowa's Prescription Monitoring Program on Opioid Pain Reliever Prescribing Patterns: An Interrupted Time Series Study 2003-2014..  Pain medicine (Malden, Mass.).  20:290-300. 2019
20. A Needs Assessment of Family Physicians to Inform Development of Educational Resources on Antipsychotic Use in Dementia..  Journal of primary care & community health.  -. 2019
21. Impact of preexisting mental illness on breast cancer endocrine therapy adherence..  Breast cancer research and treatment.  174:197-208. 2018
22. Prevalence and features of asthma-COPD overlap in the United States 2007-2012..  The clinical respiratory journal.  12:2369-2377. 2018
23. Reply to: Interventions to Reduce Antipsychotic Prescribing in Nursing Home Must Cross Healthcare Silos..  Journal of the American Geriatrics Society.  66:-. 2018
24. Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug-outcome associations: The case of clindamycin and Clostridium difficile infection..  Pharmacoepidemiology and drug safety.  27:731-739. 2018
25. Chart validation of inpatient ICD-9-CM administrative diagnosis codes for acute myocardial infarction (AMI) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database..  Pharmacoepidemiology and drug safety.  27:398-404. 2018
26. Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed Database..  Medicine.  97:-. 2018
27. Where Are Antipsychotics Prescribed in Nursing Homes Initiated?.  Journal of the American Geriatrics Society.  66:1082-1088. 2018
28. Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System..  Pharmacoepidemiology and drug safety.  27:263-271. 2018
29. Chart validation of inpatient ICD-9-CM administrative diagnosis codes for ischemic stroke among IGIV users in the Sentinel Distributed Database..  Medicine.  96:-. 2017
30. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia..  Epidemiology (Cambridge, Mass.).  28:838-846. 2017
31. Bipolar Disorder in Nursing Homes: Impact on Antipsychotic Use, Diagnosis Patterns, and New Diagnoses in People with Dementia..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  26:2-10. 2017
32. Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression..  Drugs & aging.  34:691-700. 2017
33. Exploring Electronic Communication Modes Between Iraqi Faculty and Students of Pharmacy Schools Using the Technology Acceptance Model..  American journal of pharmaceutical education.  81:-. 2017
34. Cognitive burden of anticholinergic medications in psychotic disorders..  Schizophrenia research.  129-135. 2017
35. Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes..  Alzheimer's & dementia (New York, N. Y.).  3:553-561. 2017
36. Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine..  Pharmacotherapy.  37:287-296. 2017
37. Making a Bad Diagnosis Worse? Suspect Drug Management of Urinary Incontinence in Persons with Dementia..  Journal of the American Geriatrics Society.  65:238-240. 2016
38. Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression..  American journal of Alzheimer's disease and other dementias.  31:678-686. 2016
39. Successful Comparison of US Food and Drug Administration Sentinel Analysis Tools to Traditional Approaches in Quantifying a Known Drug-Adverse Event Association..  Clinical pharmacology and therapeutics.  100:558-564. 2016
40. Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors..  Journal of comparative effectiveness research.  5:461-73. 2016
41. Validity of the Delirium Observation Screening Scale in Identifying Delirium in Home Hospice Patients..  The American journal of hospice & palliative care.  34:744-747. 2016
42. Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression..  Journal of the American Geriatrics Society.  64:1492-7. 2016
43. Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs..  American journal of hematology.  91:594-605. 2016
44. Anticholinergic medication use and falls in postmenopausal women: findings from the women's health initiative cohort study..  BMC geriatrics.  -. 2016
45. Validation of the delirium observation screening scale in a hospitalized older population..  Journal of hospital medicine.  11:494-7. 2016
46. Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression..  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.  24:485-95. 2016
47. Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study..  Journal of the American Geriatrics Society.  64:394-400. 2016
48. Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancy..  Blood.  127:200-7. 2015
49. Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women's Health Initiative..  Drugs & aging.  32:755-63. 2015
50. Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors..  Psychiatric services (Washington, D.C.).  66:1333-40. 2015
51. Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study..  Drugs & aging.  32:379-89. 2015
52. Improving antipsychotic prescribing practices in nursing facilities: The role of surveyor methods and surveying agencies in upholding the Nursing Home Reform Act..  Research in social & administrative pharmacy : RSAP.  12:91-103. 2015
53. Determination of risk factors for recurrent methicillin-resistant Staphylococcus aureus bacteremia in a Veterans Affairs healthcare system population..  Infection control and hospital epidemiology.  36:543-9. 2015
54. Caring for people with dementia and challenging behaviors in nursing homes: A needs assessment geriatric nursing..  Geriatric nursing (New York, N.Y.).  36:182-91. 2015
55. Anticholinergic drugs and health-related quality of life in older adults with dementia..  Journal of the American Pharmacists Association : JAPhA.  55:282-7. 2015
56. Potentially inappropriate anticholinergic medication use in older adults with dementia..  Journal of the American Pharmacists Association : JAPhA.  55:603-612. 2015
57. Trajectories of inflammatory markers and cognitive decline over 10 years..  Neurobiology of aging.  35:2785-2790. 2014
58. Challenges in estimating mortality risk from antipsychotics in people with Alzheimer's disease..  The American journal of psychiatry.  171:-. 2014
59. A systematic review of validated methods for identifying Bell's palsy using administrative or claims data..  Vaccine.  K7-11. 2013
60. A systematic review of validated methods for identifying transverse myelitis using administrative or claims data..  Vaccine.  K83-7. 2013
61. A systematic review of validated methods for identifying uveitis using administrative or claims data..  Vaccine.  K88-97. 2013
62. A systematic review of validated methods to capture myopericarditis using administrative or claims data..  Vaccine.  K34-40. 2013
63. A systematic review of validated methods to capture stillbirth and spontaneous abortion using administrative or claims data..  Vaccine.  K74-82. 2013
64. Methods for systematic reviews of administrative database studies capturing health outcomes of interest..  Vaccine.  K2-6. 2013
65. Prevalence and determinants of anticholinergic medication use in elderly dementia patients..  Drugs & aging.  30:837-44. 2013
66. ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA..  Neurology.  81:1484-91. 2013
67. Community-acquired pneumonia and proton pump inhibitors..  Journal of general internal medicine.  28:-. 2013
68. Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative..  BMC geriatrics.  -. 2013
69. Risks and benefits of bladder antimuscarinics among elderly residents of Veterans Affairs Community Living Centers..  Journal of the American Medical Directors Association.  14:749-60. 2013
70. Improving antipsychotic agent use in nursing homes: development of an algorithm for treating problem behaviors in dementia..  Journal of gerontological nursing.  39:24-35; quiz 36-7. 2013
71. Improving antipsychotic agent use in nursing homes: development of an algorithm for treating problem behaviors in dementia..  Journal of gerontological nursing.  39:24-35; quiz 36-7. 2013
72. No difference in extrapyramidal side effects between first-generation and second-generation antipsychotics..  Evidence-based mental health.  15:-. 2012
73. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs..  Drugs & aging.  29:639-58. 2012
74. Interpretation of positive predictive values of claims-based algorithms..  Journal of clinical epidemiology.  65:-. 2012
75. A systematic review of validated methods for identifying atrial fibrillation using administrative data..  Pharmacoepidemiology and drug safety.  21 Suppl 1:141-7. 2012
76. A systematic review of validated methods for identifying infection related to blood products, tissue grafts, or organ transplants using administrative data..  Pharmacoepidemiology and drug safety.  213-21. 2012
77. A systematic review of validated methods for identifying lymphoma using administrative data..  Pharmacoepidemiology and drug safety.  203-12. 2012
78. A systematic review of validated methods for identifying pancreatitis using administrative data..  Pharmacoepidemiology and drug safety.  194-202. 2012
79. A systematic review of validated methods for identifying seizures, convulsions, or epilepsy using administrative and claims data..  Pharmacoepidemiology and drug safety.  183-93. 2012
80. A systematic review of validated methods for identifying transfusion-related ABO incompatibility reactions using administrative and claims data..  Pharmacoepidemiology and drug safety.  230-5. 2012
81. A systematic review of validated methods for identifying transfusion-related sepsis using administrative and claims data..  Pharmacoepidemiology and drug safety.  222-9. 2012
82. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned..  Pharmacoepidemiology and drug safety.  82-9. 2012
83. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative data: summary of findings and suggestions for future research..  Pharmacoepidemiology and drug safety.  90-9. 2012
84. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction..  Pharmacoepidemiology and drug safety.  1-8. 2012
85. Prevalence and predictors of anticholinergic agents in elderly outpatients with dementia..  The American journal of geriatric pharmacotherapy.  9:434-41. 2011
86. Older adults' views about "Managing Your Medications" booklet..  Journal of applied gerontology : the official journal of the Southern Gerontological Society.  32:370-82. 2011
87. Diabetes prevalence estimates in schizophrenia and risk factor assessment..  Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.  23:117-24. 2011
88. Demographic differences in incidence for pituitary adenoma..  Pituitary.  14:23-30. 2011
89. Clostridium difficile-associated diarrhea in a tertiary care medical center..  Proceedings (Baylor University. Medical Center).  23:363-7. 2010
90. Inappropriate prescribing predicts adverse drug events in older adults..  The Annals of pharmacotherapy.  44:957-63. 2010
91. Acamprosate..  Expert opinion on drug metabolism & toxicology.  6:363-80. 2010
92. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches..  Palliative medicine.  23:257-65. 2009
93. Consistency of antidepressant and chronic nonpsychiatric medication use in a high-risk clinical population..  Research in social & administrative pharmacy : RSAP.  4:367-74. 2008
94. Assertive community treatment: a resource for the Oklahoma medical community..  The Journal of the Oklahoma State Medical Association.  101:79-82. 2008
95. Hypomania with agitation associated with varenicline use in bipolar II disorder..  The Annals of pharmacotherapy.  42:288-9. 2008
96. Premorbid intellect and current RBANS performance: discrepancy scores in three geriatric samples..  Applied neuropsychology.  15:241-9. 2008
97. Rivastigmine-induced dystonia..  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  64:2468-70. 2007
98. Clozapine-induced leukopenia successfully treated with lithium..  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  64:2027-31. 2007
99. Metabolic effects of a conversion from rosiglitazone to pioglitazone in Native American patients with type 2 diabetes..  Proceedings (Baylor University. Medical Center).  20:349-53. 2007
100. Severe hyperlipidemia associated with olanzapine and quetiapine use..  The American journal of psychiatry.  164:1614-5. 2007
101. Quetiapine for acute mania in bipolar disorder..  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.  64:1045-53. 2007
102. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity..  Journal of clinical pharmacology.  46:1481-6. 2006
103. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy..  Acta psychiatrica Scandinavica.  113:135-41. 2006
104. Common CYP450 drug interactions with psychiatric medicines: A brief review for the primary care physician..  South Dakota medicine : the journal of the South Dakota State Medical Association.  59:5-9. 2006
105. Acute ethanol intoxication after consumption of hairspray..  Pharmacotherapy.  25:1646-50. 2005
106. Methodological concerns in a trial of ziprasidone and olanzapine..  The American journal of psychiatry.  162:1391; author reply 1391-2. 2005
107. The association of weight gain and olanzapine plasma concentrations..  Journal of clinical psychopharmacology.  25:250-4. 2005
108. Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram..  Pharmacotherapy.  25:435-7. 2005
109. The concurrent use of anticholinergics and cholinesterase inhibitors: rare event or common practice?.  Journal of the American Geriatrics Society.  52:2082-7. 2004
110. Aripiprazole, a novel atypical antipsychotic drug..  Pharmacotherapy.  24:212-28. 2004
111. Depression in aging men: the role of testosterone..  Drugs & aging.  21:361-76. 2004
112. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice..  Psychopharmacology bulletin.  36:24-39. 2002
113. The relationship of an anticholinergic rating scale with serum anticholinergic activity in elderly nursing home residents..  Psychopharmacology bulletin.  36:14-9. 2002
114. Ziprasidone, a new atypical antipsychotic drug..  Pharmacotherapy.  21:717-30. 2001